Shanghai Shyndec Pharmaceutical Balans Gezondheid
Financiële gezondheid criteriumcontroles 6/6
Shanghai Shyndec Pharmaceutical has a total shareholder equity of CN¥15.2B and total debt of CN¥1.1B, which brings its debt-to-equity ratio to 7.1%. Its total assets and total liabilities are CN¥20.1B and CN¥4.9B respectively. Shanghai Shyndec Pharmaceutical's EBIT is CN¥1.5B making its interest coverage ratio -12.5. It has cash and short-term investments of CN¥5.6B.
Belangrijke informatie
7.1%
Verhouding schuld/eigen vermogen
CN¥1.08b
Schuld
| Rente dekkingsratio | -12.5x |
| Contant | CN¥5.64b |
| Aandelen | CN¥15.19b |
| Totaal verplichtingen | CN¥4.87b |
| Totaal activa | CN¥20.07b |
Recente financiële gezondheidsupdates
Geen updates
Recent updates
Analyse van de financiële positie
Kortlopende schulden: 600420's short term assets (CN¥11.6B) exceed its short term liabilities (CN¥4.6B).
Langlopende schulden: 600420's short term assets (CN¥11.6B) exceed its long term liabilities (CN¥254.9M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: 600420 has more cash than its total debt.
Schuld verminderen: 600420's debt to equity ratio has reduced from 46.9% to 7.1% over the past 5 years.
Schuldendekking: 600420's debt is well covered by operating cash flow (212.6%).
Rentedekking: 600420 earns more interest than it pays, so coverage of interest payments is not a concern.